PFIZER UNIT MUST PAY PREMPRO DAMAGES, JURY CONCLUDES
October 24, 2009
Oct. 23 (Bloomberg) -- A Pfizer Inc. unit concealed the breast-cancer risks of its hormone-replacement therapy drug Prempro and is liable for $3.7 million in damages to an Illinois woman, a Philadelphia jury ruled in the second phase of a trial.
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Jury News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
